B-lymphoblastic leukemia/lymphoma may express one or more markers of myeloid lineage, including CD13 and CD33, but is usually negative for moderate to high levels of myeloperoxidase expression (which can be assessed by flow cytometric analysis, cytochemical, or immunohistochemical staining) [2,7]. Here, MPO is linked to lymphoma.